enGene Therapeutics Inc. (ENGN) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$123.17M | -97.7% |
| 2024 | -$62.30M | -139.1% |
| 2023 | -$26.06M | -34.1% |
| 2022 | -$19.43M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$123.17M | -97.7% |
| 2024 | -$62.30M | -139.1% |
| 2023 | -$26.06M | -34.1% |
| 2022 | -$19.43M | — |